IL103928A0 - Expression of specific immunogens using viral antigens - Google Patents
Expression of specific immunogens using viral antigensInfo
- Publication number
- IL103928A0 IL103928A0 IL103928A IL10392892A IL103928A0 IL 103928 A0 IL103928 A0 IL 103928A0 IL 103928 A IL103928 A IL 103928A IL 10392892 A IL10392892 A IL 10392892A IL 103928 A0 IL103928 A0 IL 103928A0
- Authority
- IL
- Israel
- Prior art keywords
- expression
- viral antigens
- specific immunogens
- immunogens
- specific
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80510591A | 1991-12-11 | 1991-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL103928A0 true IL103928A0 (en) | 1993-04-04 |
Family
ID=25190685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL103928A IL103928A0 (en) | 1991-12-11 | 1992-11-30 | Expression of specific immunogens using viral antigens |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5591823A (fr) |
| EP (1) | EP0546787A3 (fr) |
| JP (1) | JPH05262667A (fr) |
| KR (1) | KR930013112A (fr) |
| CN (1) | CN1073878A (fr) |
| AU (1) | AU2981992A (fr) |
| BR (1) | BR9204978A (fr) |
| CA (1) | CA2084180A1 (fr) |
| CZ (1) | CZ362692A3 (fr) |
| FI (1) | FI925590A (fr) |
| HU (2) | HUT65366A (fr) |
| IL (1) | IL103928A0 (fr) |
| MX (1) | MX9207113A (fr) |
| NO (1) | NO924780L (fr) |
| SK (1) | SK362692A3 (fr) |
| TW (1) | TW239162B (fr) |
| ZA (1) | ZA929355B (fr) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69333433T2 (de) * | 1992-04-01 | 2004-12-02 | The Rockefeller University | Verfahren zur in vitro kultivierung dendritischer vorläuferzellen und deren verwendung zur immunogen herstellung |
| EP0671926B1 (fr) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Peptides immunomodulateurs |
| WO1995007099A1 (fr) * | 1993-09-09 | 1995-03-16 | The Nisshin Oil Mills, Ltd. | Vaccin et procede pour sa production |
| ES2370937T3 (es) | 1993-09-13 | 2011-12-23 | Protein Sciences Corporation | Un método para producir vacunas antigripales polivalentes a base de hemaglutinina. |
| US5762939A (en) * | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| EP2374894B1 (fr) * | 1993-09-13 | 2014-09-17 | Protein Sciences Corporation | Procédé pour la production de vaccins polyvalents contre l'hémagglutinine de la grippe |
| US6300090B1 (en) | 1994-07-29 | 2001-10-09 | The Rockefeller University | Methods of use of viral vectors to deliver antigen to dendritic cells |
| ES2300419T3 (es) * | 1995-05-26 | 2008-06-16 | Protein Sciences Corporation | Metodo para producir vacunas antigripales polivalentes a base de hemaglutinina. |
| US7659119B2 (en) | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| AU7471098A (en) * | 1997-04-30 | 1998-11-24 | Mount Sinai School Of Medicine Of The City University Of New York, The | Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents |
| US6274378B1 (en) | 1997-10-27 | 2001-08-14 | The Rockefeller University | Methods and compositions for obtaining mature dendritic cells |
| WO1999042564A2 (fr) | 1998-02-20 | 1999-08-26 | The Rockefeller University | Presentation des antigenes aux lymphocytes t au moyen de cellules d'apoptose |
| WO2002026252A1 (fr) * | 2000-08-10 | 2002-04-04 | Tsinghua University | Vaccin contre le virus de la grippe et son procede de preparation |
| KR100835873B1 (ko) | 2000-09-11 | 2008-06-09 | 다우 글로벌 테크놀로지스 인크. | 무공압 주행 타이어 지지부 및 그를 위한 착색제 |
| US20040203084A1 (en) * | 2003-04-10 | 2004-10-14 | Doug Levinson | Profiling conformational variants, antibody compositions and methods of using the same |
| CA2610667A1 (fr) * | 2005-06-01 | 2006-12-07 | Variation Biotechnologies Inc. | Formulation peptidique de vaccin antigrippal |
| CA2658227A1 (fr) | 2006-01-17 | 2007-07-26 | Health Research, Inc. | Bio-essai de suivi en heteroduplex |
| TWI615403B (zh) * | 2007-02-21 | 2018-02-21 | 腫瘤療法 科學股份有限公司 | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
| EP2012122A1 (fr) * | 2007-07-06 | 2009-01-07 | Medigene AG | Protéines structurelles de parvovirus muté |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| EP2772267B1 (fr) | 2007-08-27 | 2016-04-27 | Longhorn Vaccines and Diagnostics, LLC | Compositions immunogènes et procédés |
| TW201008574A (en) | 2008-08-19 | 2010-03-01 | Oncotherapy Science Inc | INHBB epitope peptides and vaccines containing the same |
| EP2362906B1 (fr) | 2008-10-22 | 2015-04-08 | Oncotherapy Science, Inc. | Peptide d'épitope rab6kifl/kif20a et vaccins le contenant |
| CN101708442B (zh) * | 2009-09-04 | 2011-08-24 | 山东中惠仪器有限公司 | 全自动标准气体配制装置 |
| CA2793959C (fr) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Glycoproteines du cmv et vecteurs recombines |
| CA2832109C (fr) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Glycoproteines de cmv et vecteurs recombinants cmv |
| AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
| EP2586461A1 (fr) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Particules virales dérivées d'un virus enveloppé |
| EP2679596B1 (fr) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | Variante de la protéine env du VIH-1 |
| US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
| EP2873423B1 (fr) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Trimères de glycoprotéines d'enveloppe du vih -1 soluble |
| US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US10063211B2 (en) * | 2016-02-03 | 2018-08-28 | Qualcomm Incorporated | Compact bypass and decoupling structure for millimeter-wave circuits |
| CN109073639B (zh) | 2016-02-03 | 2022-04-01 | Cg探索股份有限公司 | 具有异源表位和/或改变的成熟切割位点的流感血凝素的组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0339504A3 (fr) * | 1988-04-26 | 1990-09-12 | The Du Pont Merck Pharmaceutical Company | Virus d'immunodéficience humaine (HIV) peptide env-codé capable de provoquer les anticorps inhibiteurs du HIV dans les mammifères |
| US5166057A (en) * | 1989-08-28 | 1992-11-24 | The Mount Sinai School Of Medicine Of The City University Of New York | Recombinant negative strand rna virus expression-systems |
| EP0492920A1 (fr) * | 1990-12-24 | 1992-07-01 | Merck & Co. Inc. | Vaccine chimérique de l'influenza et de l'HIV |
-
1992
- 1992-11-30 IL IL103928A patent/IL103928A0/xx unknown
- 1992-11-30 CA CA002084180A patent/CA2084180A1/fr not_active Abandoned
- 1992-12-01 JP JP4321768A patent/JPH05262667A/ja active Pending
- 1992-12-02 AU AU29819/92A patent/AU2981992A/en not_active Abandoned
- 1992-12-02 ZA ZA929355A patent/ZA929355B/xx unknown
- 1992-12-07 EP EP19920311146 patent/EP0546787A3/en not_active Withdrawn
- 1992-12-07 TW TW081109778A patent/TW239162B/zh active
- 1992-12-09 MX MX9207113A patent/MX9207113A/es unknown
- 1992-12-09 FI FI925590A patent/FI925590A/fi not_active Application Discontinuation
- 1992-12-09 KR KR1019920023656A patent/KR930013112A/ko not_active Application Discontinuation
- 1992-12-10 BR BR9204978A patent/BR9204978A/pt not_active Application Discontinuation
- 1992-12-10 CZ CS923626A patent/CZ362692A3/cs unknown
- 1992-12-10 CN CN92113703A patent/CN1073878A/zh active Pending
- 1992-12-10 NO NO92924780A patent/NO924780L/no unknown
- 1992-12-10 SK SK3626-92A patent/SK362692A3/sk unknown
- 1992-12-11 HU HU9203931A patent/HUT65366A/hu unknown
-
1993
- 1993-12-17 US US08/169,813 patent/US5591823A/en not_active Expired - Lifetime
-
1995
- 1995-06-27 HU HU95P/P00456P patent/HU211548A9/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI925590A (fi) | 1993-06-12 |
| NO924780D0 (no) | 1992-12-10 |
| HU9203931D0 (en) | 1993-04-28 |
| JPH05262667A (ja) | 1993-10-12 |
| CZ362692A3 (en) | 1994-02-16 |
| SK362692A3 (en) | 1995-11-08 |
| BR9204978A (pt) | 1993-06-15 |
| TW239162B (fr) | 1995-01-21 |
| ZA929355B (en) | 1994-06-02 |
| NO924780L (no) | 1993-06-14 |
| HU211548A9 (en) | 1995-12-28 |
| CN1073878A (zh) | 1993-07-07 |
| MX9207113A (es) | 1994-05-31 |
| US5591823A (en) | 1997-01-07 |
| EP0546787A2 (fr) | 1993-06-16 |
| EP0546787A3 (en) | 1994-06-01 |
| HUT65366A (en) | 1994-05-02 |
| AU2981992A (en) | 1993-06-17 |
| KR930013112A (ko) | 1993-07-21 |
| CA2084180A1 (fr) | 1993-06-12 |
| FI925590A0 (fi) | 1992-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0546787A3 (en) | Expression of specific immunogens using viral antigens | |
| PL324906A1 (en) | Vaccines against viral hepatitis of c type | |
| GB8822749D0 (en) | Vaccine containing tumour antigens & adjuvants | |
| PL321966A1 (en) | Vaccine against viral hepatitis of b type | |
| AU4325089A (en) | Viral vaccines | |
| GB8907914D0 (en) | Vaccine preparation | |
| EP0391997A4 (en) | Vaccine | |
| HUP9601466A2 (en) | Adjuvants for viral vaccines | |
| HUP9601462A2 (en) | Adjuvants for viral vaccines | |
| LTIP335A (en) | Vaccine for human immunodeficiency virus | |
| IL79740A0 (en) | Hepatitis vaccine | |
| GB8704647D0 (en) | Vaccine | |
| HUT65487A (en) | Vaccine containing modified herpesvirus | |
| GB9020683D0 (en) | Isolation of dna | |
| OA09636A (en) | Vaccine | |
| ZA94740B (en) | Expression of pretective antigens | |
| GB9020799D0 (en) | Viral vaccines | |
| GB9104903D0 (en) | Viral vaccines | |
| GB8712042D0 (en) | Virus & vaccine | |
| GB8622883D0 (en) | Expression of hepatitis b viral antigens | |
| GB9122301D0 (en) | Novel antigens | |
| GB9117602D0 (en) | Novel antigens | |
| HU907120D0 (en) | In-vitro mass microproliferation of lilies by means of histogenesis | |
| GB8621578D0 (en) | Hepatitis b viral antigens | |
| ZA891686B (en) | Improvements relating to antigens |